NEVRO CORP.
NVRO Real Time Price USDRecent trades of NVRO by members of U.S. Congress
No Congress Trading data for this ticker
Congress Trading Dashboard
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
---|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
---|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
---|
Recently reported changes by institutional investors
Quarterly net insider trading by NVRO's directors and management
No recent Insider Trading for this ticker
Insider Trading DashboardGovernment lobbying spending instances
-
$40,000 Oct 17, 2024 Issue: Medicare/Medicaid
-
$40,000 Jul 15, 2024 Issue: Medicare/Medicaid
-
$40,000 Apr 17, 2024 Issue: Medicare/Medicaid
-
$40,000 Oct 20, 2023 Issue: Medicare/Medicaid
-
$40,000 Jul 20, 2023 Issue: Medicare/Medicaid
-
$40,000 May 01, 2023 Issue: Medicare/Medicaid
-
$10,000 Jul 20, 2020 Issue: Medicare/Medicaid
-
$30,000 Jun 03, 2020 Issue: Medicare/Medicaid
-
$30,000 Jan 21, 2020 Issue: Medicare/Medicaid Taxation/Internal Revenue Code
-
$30,000 Oct 18, 2019 Issue: Taxation/Internal Revenue Code Medicare/Medicaid
-
$30,000 Jul 12, 2019 Issue: Medicare/Medicaid
-
$30,000 Apr 04, 2019 Issue: Medicare/Medicaid
-
$40,000 Jan 09, 2019 Issue: Medicare/Medicaid
-
$40,000 Oct 10, 2018 Issue: Medicare/Medicaid
-
$50,000 Jul 17, 2018 Issue: Health Issues
-
$40,000 Jul 09, 2018 Issue: Medicare/Medicaid
-
$30,000 Jan 19, 2018 Issue: Health Issues Medicare/Medicaid
Estimated quarterly lobbying spending
New patents grants
-
Patent Title: Neurostimulation waveforms having a base component and a high frequency component, and associated systems and methods Nov. 05, 2024
-
Patent Title: Electrical therapy applied to the brain with increased efficacy and/or decreased undesirable side effects, and associated systems and methods Oct. 01, 2024
-
Patent Title: Methods and systems for disease treatment using electrical stimulation Jun. 04, 2024
-
Patent Title: Neurostimulation for treating sensory deficits, and associated systems and methods May. 21, 2024
-
Patent Title: Variable amplitude signals for neurological therapy, and associated systems and methods Apr. 02, 2024
-
Patent Title: Electrical therapy applied to the brain with increased efficacy and/or decreased undesirable side effects, and associated systems and methods Apr. 02, 2024
-
Patent Title: Devices for controlling spinal cord modulation for inhibiting pain, and associated systems and methods, including controllers for automated parameter selection Mar. 19, 2024
-
Patent Title: Systems and methods for producing asynchronous neural responses to treat pain and/or other patient conditions Jan. 30, 2024
-
Patent Title: Selective high frequency spinal cord modulation for inhibiting pain, including cephalic and/or total body pain with reduced side effects, and associated systems and methods Jan. 30, 2024
-
Patent Title: Systems and methods for direct suppression of nerve cells Nov. 21, 2023
-
Patent Title: Motor function in spinal cord injury patients via electrical stimulation, and associated systems and methods Oct. 31, 2023
-
Patent Title: Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods Oct. 17, 2023
-
Patent Title: Implanted pulse generators with reduced power consumption via signal strength/duration characteristics, and associated systems and methods Sep. 26, 2023
-
Patent Title: Spinal cord modulation for inducing paresthetic and anesthetic effects, and associated systems and methods Sep. 19, 2023
-
Patent Title: Paddle leads and delivery tools, and associated systems and methods Sep. 19, 2023
-
Patent Title: 2.4 ghz radio antenna for implanted medical devices, and associated systems and methods Jun. 27, 2023
-
Patent Title: Efficient use of an implantable pulse generator battery, and associated systems and methods Apr. 25, 2023
-
Patent Title: External neurostimulator Apr. 25, 2023
-
Patent Title: Sensory threshold adaptation for neurological therapy screening and/or electrode selection, and associated systems and methods Mar. 14, 2023
-
Patent Title: Treatment of congestive heart failure with electrical stimulation, and associated systems and methods Mar. 07, 2023
-
Patent Title: Ramped therapeutic signals for modulating inhibitory interneurons, and associated systems and methods Feb. 28, 2023
-
Patent Title: Power control circuit for sterilized devices, and associated systems and methods Feb. 07, 2023
-
Patent Title: Therapeutic modulation to treat blood glucose abnormalities, including type 2 diabetes, and/or reduce hba1c levels, and associated systems and methods Dec. 27, 2022
-
Patent Title: Variable amplitude signals for neurological therapy, and associated systems and methods Oct. 04, 2022
-
Patent Title: Handheld remote controller Sep. 27, 2022
-
Patent Title: High frequency electromagnetic stimulation for modulating cells, including spontaneously active and quiescent cells, and associated systems and methods Sep. 20, 2022
-
Patent Title: Leads having sidewall openings, and associated systems and methods Aug. 23, 2022
-
Patent Title: Neurological stimulation lead anchors and associated tools, and methods Jul. 19, 2022
-
Patent Title: Systems and methods for positioning implanted devices in a patient Jul. 12, 2022
-
Patent Title: Neuromodulation for altering autonomic functions, and associated systems and methods May. 03, 2022
-
Patent Title: Selective high frequency spinal cord modulation for inhibiting pain, including cephalic and/or total body pain with reduced side effects, and associated systems and methods Apr. 12, 2022
-
Patent Title: Charger controller Apr. 05, 2022
-
Patent Title: Autonomic nervous system control via high frequency spinal cord modulation, and associated systems and methods Feb. 15, 2022
-
Patent Title: Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods Jan. 25, 2022
-
Patent Title: Spinal cord modulation for inducing paresthetic and anesthetic effects, and associated systems and methods Jan. 25, 2022
-
Patent Title: Systems and methods for automatically programming patient therapy devices Dec. 14, 2021
-
Patent Title: 2.4 ghz radio antenna for implanted medical devices, and associated systems and methods Oct. 19, 2021
-
Patent Title: Treatment of neurodegenerative disease with high frequency stimulation, and associated systems and methods Sep. 21, 2021
-
Patent Title: Electrical therapy applied to the brain with increased efficacy and/or decreased undesirable side effects, and associated systems and methods Sep. 21, 2021
-
Patent Title: Lead insertion devices and associated systems and methods Aug. 31, 2021
-
Patent Title: Systems and methods for extending the life of an implanted pulse generator battery Aug. 17, 2021
-
Patent Title: Motor function in spinal cord injury patients via electrical stimulation, and associated systems and methods Jul. 13, 2021
-
Patent Title: Paddle leads and delivery tools, and associated systems and methods Apr. 20, 2021
-
Patent Title: Methods for forming implantable signal generators with molded headers Mar. 16, 2021
-
Patent Title: Power control circuit for sterilized devices, and associated systems and methods Mar. 02, 2021
-
Patent Title: Systems and methods for producing asynchronous neural responses to treat pain and/or other patient conditions Feb. 16, 2021
-
Patent Title: Medical device communication and charging assemblies for use with implantable signal generators, and associated systems and methods Feb. 16, 2021
-
Patent Title: Implanted pulse generators with reduced power consumption via signal strength/duration characteristics, and associated systems and methods Jan. 05, 2021
-
Patent Title: Physician programmer with enhanced graphical user interface, and associated systems and methods Nov. 24, 2020
-
Patent Title: Systems and methods for identifying and treating patients with high-frequency electrical signals Oct. 13, 2020
Federal grants, loans, and purchases
- $58,855 2024-06-17 00:00:00 Agency: Department of Veterans Affairs
- $58,855 2024-05-03 00:00:00 Agency: Department of Veterans Affairs
- $58,279 2024-01-26 00:00:00 Agency: Department of Veterans Affairs
- $38,950 2024-01-23 00:00:00 Agency: None
- $38,950 2024-01-23 00:00:00 Agency: Department of Veterans Affairs
- $38,950 2024-01-23 00:00:00 Agency: Department of Veterans Affairs
- $38,950 2024-01-23 00:00:00 Agency: Department of Veterans Affairs
- $29,725 2023-12-18 00:00:00 Agency: Department of Veterans Affairs
- $41,024 2023-11-24 00:00:00 Agency: Department of Veterans Affairs
- $41,024 2023-11-03 00:00:00 Agency: Department of Veterans Affairs
- $38,950 2023-10-25 00:00:00 Agency: Department of Veterans Affairs
- $38,950 2023-10-25 00:00:00 Agency: Department of Veterans Affairs
- $41,024 2023-09-25 00:00:00 Agency: Department of Veterans Affairs
- $41,024 2023-09-25 00:00:00 Agency: Department of Veterans Affairs
- $41,024 2023-09-09 00:00:00 Agency: Department of Veterans Affairs
- $43,024 2023-09-05 00:00:00 Agency: Department of Veterans Affairs
- $40,258 2023-08-18 00:00:00 Agency: Department of Veterans Affairs
- $37,900 2023-08-11 00:00:00 Agency: Department of Veterans Affairs
- $41,024 2023-08-10 00:00:00 Agency: Department of Veterans Affairs
- $41,024 2023-08-08 00:00:00 Agency: Department of Veterans Affairs
- $38,950 2023-08-08 00:00:00 Agency: Department of Veterans Affairs
- $35,000 2023-08-01 00:00:00 Agency: Department of Veterans Affairs
- $36,950 2023-07-13 00:00:00 Agency: Department of Veterans Affairs
- $36,950 2023-07-13 00:00:00 Agency: Department of Veterans Affairs
- $38,950 2023-07-13 00:00:00 Agency: Department of Veterans Affairs
- $38,825 2023-07-12 00:00:00 Agency: Department of Veterans Affairs
- $44,200 2023-07-07 00:00:00 Agency: Department of Veterans Affairs
- $41,024 2023-07-03 00:00:00 Agency: Department of Veterans Affairs
- $36,225 2023-05-31 00:00:00 Agency: Department of Veterans Affairs
- $36,300 2023-05-30 00:00:00 Agency: Department of Veterans Affairs
- $29,725 2023-05-19 00:00:00 Agency: Department of Veterans Affairs
- $37,450 2023-05-19 00:00:00 Agency: Department of Veterans Affairs
- $36,950 2023-05-09 00:00:00 Agency: Department of Veterans Affairs
- $36,950 2023-05-09 00:00:00 Agency: Department of Veterans Affairs
- $36,950 2023-05-09 00:00:00 Agency: Department of Veterans Affairs
- $36,950 2023-04-24 00:00:00 Agency: Department of Veterans Affairs
- $31,775 2023-04-17 00:00:00 Agency: Department of Veterans Affairs
- $46,225 2023-04-12 00:00:00 Agency: Department of Veterans Affairs
- $29,975 2023-04-07 00:00:00 Agency: Department of Veterans Affairs
- $36,950 2023-03-31 00:00:00 Agency: Department of Veterans Affairs
- $36,950 2023-03-31 00:00:00 Agency: Department of Veterans Affairs
- $27,875 2023-03-28 00:00:00 Agency: Department of Veterans Affairs
- $29,975 2023-03-24 00:00:00 Agency: Department of Veterans Affairs
- $36,950 2023-03-17 00:00:00 Agency: Department of Veterans Affairs
- $36,950 2023-03-10 00:00:00 Agency: Department of Veterans Affairs
- $41,024 2023-02-27 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $41,024 2023-02-17 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $33,250 2023-01-18 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $44,350 2023-01-09 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $36,950 2022-12-30 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
Estimated quarterly amount awarded from public contracts
Number of mentions of NVRO in WallStreetBets Daily Discussion
Recent insights relating to NVRO
Recent picks made for NVRO stock on CNBC
ETFs with the largest estimated holdings in NVRO
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view NVRO Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.